HKSE - Delayed Quote HKD

Alphamab Oncology (9966.HK)

Compare
3.740 -0.100 (-2.60%)
At close: 4:08 PM GMT+8
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Assets
2,137,113.000
2,117,531.000
2,705,091.000
2,639,522.000
--
Total Liabilities Net Minority Interest
465,001.000
559,859.000
834,802.000
366,438.000
--
Total Equity Gross Minority Interest
1,672,112.000
1,557,672.000
1,870,289.000
2,273,084.000
--
Total Capitalization
1,847,112.000
1,707,672.000
2,024,115.000
2,294,434.000
--
Common Stock Equity
1,672,112.000
1,557,672.000
1,870,289.000
2,273,084.000
--
Capital Lease Obligations
7,080.000
20,392.000
33,454.000
13,455.000
--
Net Tangible Assets
1,651,421.000
1,536,487.000
1,848,609.000
2,250,909.000
--
Working Capital
1,291,692.000
1,109,618.000
1,479,289.000
1,869,693.000
--
Invested Capital
1,922,112.000
1,882,672.000
2,474,105.000
2,482,434.000
--
Tangible Book Value
1,651,421.000
1,536,487.000
1,848,609.000
2,250,909.000
--
Total Debt
257,080.000
345,392.000
637,270.000
222,805.000
--
Net Debt
--
--
--
24,029.000
--
Share Issued
964,843.807
939,716.387
936,985.020
934,939.370
--
Ordinary Shares Number
964,843.807
939,716.387
936,985.020
934,939.370
--
12/31/2019 - 12/12/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers